Halozyme Therapeutics Inc (NASDAQ:HALO)

U.S. Markets are not yet open, but HALO is being traded in the pre-market session. Pre-Market quote »
13.31
Delayed Data
As of Mar 26
 +0.02 / +0.15%
Today’s Change
6.88
Today|||52-Week Range
16.55
+37.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues56.1M42.3M54.8M75.3M
 
 
 
 
 
Cost of Goods Sold257.8K1.1M5.0M22.7M
 
 
 
 
 
Depreciation And Amortization1.1M1.1M1.2M--
 
 
 
 
 
Operating ExpensesGross Income54.7M40.2M48.6M52.6M
 
 
 
 
 
General Expenses74.6M93.8M129.0M115.6M
 
 
 
 
 
Research And Development57.6M69.0M96.6M79.7M
 
 
 
 
 
Total Operating Expenses75.9M96.0M135.2M138.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.8M-53.6M-80.4M-63.0M
 
 
 
 
 
Interest Expense On Debt0.000.003.3M5.6M
 
 
 
Other Expenses5.6K14.4K0.00--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.8M-53.6M-83.5M-68.4M
 
 
 
 
 
Net Income-19.8M-53.6M-83.5M-68.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.6M111.1M112.8M122.7M
 
 
 
 
 
Shares To Calculate EPS Diluted102.6M111.1M112.8M122.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.48-$0.74-$0.56
 
 
 
 
 
EPS Diluted-$0.19-$0.48-$0.74-$0.56
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account